Подписаться
Maud de Klerk-Starmans
Maud de Klerk-Starmans
Philips Research
Подтвержден адрес электронной почты в домене viecuri.nl
Название
Процитировано
Процитировано
Год
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
5172015
Predicting outcomes in radiation oncology—multifactorial decision support systems
P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ...
Nature reviews Clinical oncology 10 (1), 27-40, 2013
4462013
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 5203, 2014
2302014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 5203, 2014
2302014
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ...
Mutation Research/Reviews in Mutation Research 764, 16-30, 2015
2042015
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung …
P Lambin, SF Petit, HJWL Aerts, WJC van Elmpt, CJG Oberije, ...
Radiotherapy and oncology 96 (2), 145-152, 2010
882010
BPG: Seamless, automated and interactive visualization of scientific data
C P’ng, J Green, LC Chong, D Waggott, SD Prokopec, M Shamsi, ...
BMC bioinformatics 20, 1-5, 2019
862019
Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors
D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ...
International Journal of Cancer 140 (3), 662-673, 2017
792017
Impact of supervised gene signatures of early hypoxia on patient survival
R Seigneuric, MHW Starmans, G Fung, B Krishnapuram, DSA Nuyten, ...
Radiotherapy and oncology 83 (3), 374-382, 2007
792007
Epigenetics in radiotherapy: Where are we heading?
KM Smits, V Melotte, HEC Niessen, L Dubois, C Oberije, EGC Troost, ...
Radiotherapy and Oncology 111 (2), 168-177, 2014
602014
The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia
MBE Schaaf, D Cojocari, TG Keulers, B Jutten, MH Starmans, MC de Jong, ...
Radiotherapy and Oncology 108 (3), 529-534, 2013
572013
A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing
AC Nichols, M Chan-Seng-Yue, J Yoo, W Xu, S Dhaliwal, J Basmaji, ...
International Scholarly Research Notices 2012, 2012
562012
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
MHW Starmans, B Krishnapuram, H Steck, H Horlings, DSA Nuyten, ...
British journal of cancer 99 (11), 1884-1890, 2008
552008
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer
MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ...
Radiotherapy and Oncology 102 (3), 436-443, 2012
512012
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ...
Cancer medicine 2 (6), 916-924, 2013
462013
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ...
Cancer Medicine 2 (6), 916-924, 2013
462013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer
T John, MHW Starmans, YT Chen, PA Russell, SA Barnett, SC White, ...
PloS one 8 (7), e67876, 2013
442013
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
NS Fox, MHW Starmans, S Haider, P Lambin, PC Boutros
BMC bioinformatics 15, 1-14, 2014
322014
Pathway-based subnetworks enable cross-disease biomarker discovery
S Haider, CQ Yao, VS Sabine, M Grzadkowski, V Stimper, MHW Starmans, ...
Nature communications 9 (1), 4746, 2018
312018
Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers
L Dodbiba, J Teichman, A Fleet, H Thai, MHW Starmans, R Navab, ...
PloS one 10 (3), e0121872, 2015
262015
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20